Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation

Measurable residual disease (MRD) is an adverse prognostic factor in adult patients with acute lymphoblastic leukemia (ALL) undergoing hematopoietic cell transplant (HCT). Next-generation sequencing (NGS) can detect MRD with a sensitivity of 10(–6), but the prognostic value of NGS-based MRD in adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Emily C., Dekker, Simone E., Sabile, Jean M. G., Torelli, Stefan, Zhang, Amy, Miller, Katharine, Shiraz, Parveen, Hayes-Lattin, Brandon, Leonard, Jessica T., Muffly, Lori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345845/
https://www.ncbi.nlm.nih.gov/pubmed/37196642
http://dx.doi.org/10.1182/bloodadvances.2023009856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345845/
https://www.ncbi.nlm.nih.gov/pubmed/37196642
http://dx.doi.org/10.1182/bloodadvances.2023009856

Ejemplares similares